Drug Type Chemical drugs |
Synonyms alpha- Crocin |
Target |
Mechanism Hormone sensitive lipase inhibitors, Lipid peroxidation inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC44H64O24 |
InChIKeySEBIKDIMAPSUBY-RTJKDTQDSA-N |
CAS Registry42553-65-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lipid Metabolism Disorders | Phase 3 | - | - | |
Lipid Metabolism Disorders | Phase 3 | - | - | |
Lipid Metabolism Disorders | Phase 3 | - | - | |
Stroke | Phase 3 | - | - | |
Stroke | Phase 3 | - | - | |
Stroke | Phase 3 | - | - | |
Osteoarthritis, Knee | Preclinical | IR | 20 Jul 2016 | |
Malaria | Preclinical | - | - | |
Malaria | Discovery | - | - | |
Malaria | Discovery | - | - |
Phase 2/3 | - | qtisqvphzp(towsqvkpbw) = dsvhwufhij jvryazcrfo (xqceagwqjl ) | - | 16 Sep 2021 | |||
Placebo | qtisqvphzp(towsqvkpbw) = rhwiompopb jvryazcrfo (xqceagwqjl ) | ||||||
Phase 2 | 59 | (leedpsqspc) = ffthtbtrrg syjzlfccxu (ujljusfcaw ) View more | Negative | 01 Jul 2023 | |||
Placebo | (leedpsqspc) = kpyicczlrm syjzlfccxu (ujljusfcaw ) View more |